Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Methotrexate dose delivery is...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplant
Show other versions (1)
Bibliographic Details
Main Authors:
Medd, P
,
Monk, I
,
Danby, R
,
Malladi, R
,
Clifford, R
,
Ellis, A
,
Roberts, D
,
Hatton, C
,
Vyas, P
,
Littlewood, T
,
Peniket, A
Format:
Journal article
Published:
2011
Holdings
Description
Other Versions (1)
Similar Items
Staff View
Similar Items
Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplant.
by: Medd, P, et al.
Published: (2011)
Classic and overlap chronic graft-versus-host disease after T-replete reduced intensity conditioned sibling allograft usually starts within a year, causes prolonged morbidity but low mortality and is influenced by prophylactic methotrexate and ciclosporin dosing
by: Medd, P, et al.
Published: (2010)
NIH consensus chronic GvHD following T-replete reduced-intensity conditioning sibling allograft usually develops within a year, causes prolonged morbidity but low mortality and is influenced by prophylactic methotrexate dose
by: Medd, P, et al.
Published: (2010)
Analysis of factors affecting outcome in recipients of bone marrow transplantation for myelodysplasia; a single centre's experience over a nine year period
by: Stoll, V, et al.
Published: (2010)
Developing a dedicated dermatology service for allogeneic bone marrow transplant recipients
by: Danby, R, et al.
Published: (2017)